Abstract
Transplantation results are significantly better when organs are obtained from live donors compared with organs from brain-dead and from nonheart- beating donors. This outcome is closely related to acute and widespread physiological changes occurring during brain death that, if untreated, cause organic deterioration and cardiac arrest. Furthermore, inflammatory and hormonal changes, if not carefully diagnosed and treated, may adversely affect donor organ function after transplantation and susceptibility to rejection.
In brain death, the impairments eventually developed are initially caused by the physiological response and then aggravated by the lesion/injury and the medications given. Cardiovascular changes in the donor during the observation period and the harvesting procedure may jeopardize the functionality of potential transplantable organs. The increasing intracranial pressure produces a compensatory arterial hypertension that is followed by sympathetic overactivity, which in turn induces a “catecholamine storm” with increased cardiac output, heart rate, and systemic vascular resistance. Treatment algorithms for donor management in some common clinical settings are shown. Management of glycemic homeostatic derangements, acid-base alterations, fluid, electrolyte changes and pulmonary changes are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wilhelm MJ, Pratschke J, Beato F, Taal M, Kusaka M, Hancock WW, Tilney NL (2000) Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 102(19):2426–2433
Zweers N, Petersen AH, Van Der Hoeven JA, De Haan A, Ploeg RJ, De Leij LF, Prop J (2004) Donor brain death aggravates chronic rejection after lung transplantation in rats. Transplantation 78(9):1251–1258
Pratschke J, Wilhelm MJ, Laskowski I, Kusaka M, Beato F, Tullius SG, Neuhaus P, Hancock WW, Tilney NL (2001) Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 12(11):2474–2481
Barklin A (2009) Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 53:425–435
Avlonitis VS, Wigfield CH, Kirby JA, Dark JH (2005) The hemodynamic mechanisms of lung injury and systemic inflammatory response following brain death in the transplant donor. Am J Transplant 5(4 Pt 1):684–693
Bos E, Leuvenink H, van Goor H, Ploeg RJ (2007) Kidney grafts from brain dead donors: inferior quality or opportunity for improvement? Kidney Int 72:797–805
Weiss S, Kotsch K, Francuski M et al (2007) Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 7:1584–1593
Kutsogiannis DJ, Pagliarello G, Doig C, Ross H, Shemie SD (2006) Medical management to optimize donor organ potential: review of the literature. Can J Anaesth 53:820–830
Rangel-Castillo L, Gopinath S, Robertson CS (2008) Management of intracranial hypertension. Neurol Clin 26:521–541
Docze T (1993) Volume regulation of the brain tissue – a survey. Acta Neurochir (Wien) 121:1–8
Langfit TW, Weinstein JD, Kassell NF (1965) Cerebral vasomotor paralysis produced by intracranial hypertension. Neurology 15:622–641
Miller JD, Sullivan HG (1979) Severe intracranial hypertension. Int Anesthesiol Clin 17:19–75
Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, Glynn RJ (2000) Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 36:801–807
Smith M (2004) Physiologic changes during brain stem death – lessons for management of the organ donor. J Heart Lung Transplant 23:217–222
Agrawal A, Timothy J, Cincu R, Agarwal T, Waghmare LB (2008) Bradycardia in neurosurgery. Clin Neurol Neurosurg 110:321–327
Bugge J (2009) Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand 53:1239–1250
Smith M (2004) Physiologic changes during brain stem death—lessons for management of the organ donor. J Heart Lung Transplant 23(Suppl 9):S217–S222
McKeown DW, Bonser RS, Kellum JA (2012) Management of the heartbeating brain-dead organ donor. Br J Anaesth 108(suppl 1):i96–i107
Dujardin KS, McCully RB, Wijdicks EF et al (2001) Myocardial dysfunction associated with brain death: clinical, echocardiographic, and pathologic features. J Heart Lung Transplant 20:350–357
Venkateswaran RV, Townend JN, Wilson IC, Mascaro JG, Bonser RS, Steeds RP (2010) Echocardiography in the potential heart donor. Transplantation 89:894–901
Potapov EV, Ivanitskaja EA, Loebe M, Mockel M, Muller C, Sodian R, Meyer R, Hetzer R (2001) Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure. Transplantation 71:1394–1400
Gelb AW, Robertson KM (1990) Anaesthetic management of brain dead for organ donation. Can J Anaesth 37:806–818
Powner DJ, Crommett JW (2003) Advanced assessment of hemodynamic parameters during donor care. Prog Transplant 13:249–257
Unverferth DR, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54:147–152
Rosner MJ (1993) Pathophysiology and management of increased intracranial pressure. In: Andrews BT (ed) Neurosurgical intensive care, International Edition. New York :McGraw Hill
Harukuni I, Kirsch JR, Bhardwaj A (2002) Cerebral resuscitation: role of osmotherapy. J Anesth 16:229–237
Schunelle P, Berger S, De Boer J, Persijn G, Der Wonde FJ (2001) Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 72:455–463
Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR (2003) Aggressive pharmacological donor management results in more transplanted organs. Transplantation 75:482–487
Novitzky D, Cooper DK (2014) Thyroid hormone and the stunned myocardium. J Endocrinol 223(1):R1–R8
Mi Z, Novitzky D, Collins JF, Cooper DKC (2015) The optimal hormonal replacement modality selection for multiple organ procurement from brain-dead organ donors. Clin Epidemiol 7:17–27
Powner DJ, Kellum JA, Darby JM (2000) Abnormalities in fluids, electrolytes, and metabolism of organ donors. Prog Transplant 10:88–96
Powner DJ, Kellum JA (2000) Maintaining acid–base in organ donors. Prog Transplant 10:98–105
Mizock BA, Falk JL (1992) Lactic acidosis in critical illness. Crit Care Med 20:80–93
Oh MS, Carroll HJ (2000) External balance of electrolytes and acids and alkali. In: Seldin DW, Giebisch G (eds) The kidney: physiology & pathophysiology. Lippincott Williams & Wilkins, Philadelphia, pp 33–60
Kazemeyni SM, Esfahani F (2008) Influence of hypernatremia and polyuria of brain-dead donors before organ procurement on kidney allograft function. Urol J 5:173–177
Katz MA (1973) Hyperglycemia-induced hyponatremia–calculation of expected serum sodium depression. N Engl J Med 289:843–844
Mandal AK (1997) Hypokalemia and hyperkalemia. Med Clin North Am 81:611–639, - Wrenn KD, Slovis CM, Slovis BS. The ability of the physician to predict hyperkalemia from the ECG. Ann Emerg Med. 1991;20:1229–1232
Allon M (1993) Treatment and prevention of hyperkalemia in end-stage renal disease. Kidney Int 43:1197–1209
Ahee P, Crowe AV (2000) The management of hyperkalaemia in the emergency department. J Accid Emerg Med 17:188–191
Martin KJ, Gonzalez EA, Slatopolsky E (2009) Clinical consequences and management of hypomagnesemia. J Am Soc Nephrol 20:2291–2295
Bushinsky DA, Monk RD (1998) Calcium. Lancet 352:306–311
Hirschl MM, Matzner MP, Huber WO et al (1996) Effect of desmopressin substitution during organ procurement on early renal allograft function. Nephrol Dial Transplant 11:173–176
Shah V, Bhosale G (2006) Organ donor problems and their management. Indian J Crit Care Med 10:29–34
Ramos HC, Lopez R (2002) Critical care management of the brain-dead organ donor. Curr Opin Organ Transplant 7:70–75
Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342(18):1301–1308
Mascia L, Pasero D, Slutsky A et al (2010) Effect of a lung protective strategy for organ donors an eligibility and availability of lungs for transplantation. JAMA 304:2620–2627
Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903
Bonten MJ, Bergmans DC, Stobberingh EE, van der Geest S, De Leeuw PW, van Tiel FH, Gaillard CA (1997) Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med 156:1820–1824
Levy JH (2006) Massive transfusion coagulopathy. Semin Hematol 43(1 Suppl 1):S59–S63
Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan LS, Demetriades D (2009) Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma 66:55–61, discussion 61–62
Barklin A, Tønnesen E, Ingerslev J, Sørensen B, Fenger-Eriksen C (2009) Coagulopathy during induced severe intracranial hypertension in a porcine donor model. Anesthesiology 110:1287–1292
Hefty TR, Cotterell LW, Fraser SC, Goodnight SH, Hatch TR (1993) Disseminated intravascular coagulation in cadaveric organ donors. Incidence and effect on renal transplantation. Transplantation 55:442–443
Valdivia M, Chamorro C, Romera MA, Balandín B, Pérez M (2007) Effect of posttraumatic donor’s disseminated intravascular coagulation in intrathoracic organ donation and transplantation.Transplant Proc. Sep;39:2427–8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Grande, A.M., Aseni, P. (2016). Management of Hemodynamic and Metabolic Impairments in Heart-Beating Donors. In: Aseni, P., Grande, A., De Carlis, L. (eds) Multiorgan Procurement for Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-319-28416-3_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-28416-3_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28414-9
Online ISBN: 978-3-319-28416-3
eBook Packages: MedicineMedicine (R0)